PATENT CLAIM ANALYSIS

Application Number: 16326049
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "504000"]

Abstract:
Methods and compositions are provided for inhibiting, preventing, ameliorating and/or reducing damage to DNA in non-cancerous cells in a subject undergoing chemotherapeutic treatment and/or radiation treatment of cancer cells in the subject, comprising administering to the subject one or more compounds of arsenic in a therapeutically effective amount prior to chemotherapeutic treatment and/or radiation treatment.

Claim (Index 3):
A method of preventing and/or reducing the risk of developing a secondary malignancy in a subject undergoing radiation treatment and/or chemotherapeutic treatment of cancer cells present in the subject, comprising:\n a) administering to the subject one or more compounds of arsenic in a protective amount of from about 1 \u03bcg/kg/day to about 125m/kg/day, wherein the one or more compounds of arsenic are administered to the subject at least one day prior to administration of radiation and/or one or more chemotherapeutic agents to the subject; and b) administering to the subject radiation and/or one or more chemotherapeutic agents subsequent to administration of the one or more of the compounds of arsenic.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.51282
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12945430', '13124376', '14104752', '14802398', '14103359']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7087905044064291
- 35 USC 102 Novelty (BERT): 0.5255624962231679
- Combined Prediction Score: 0.6904677035881029
- Mean Citation Score: 265.41386800000004
- Max Citation Score: 321.22668
- Similarity Product: 248.51045066463945

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test